Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Virbac is a French multinational pharmaceutical company founded in 1968 by veterinarian Pierre-Richard Dick. It is dedicated exclusively to animal health, developing, manufacturing, and distributing a wide range of vaccines and medicines for the prevention and treatment of diseases in both companion and food-producing animals. With a global presence, Virbac focuses on innovation and meeting the specific needs of veterinarians, farmers, and pet owners worldwide.
The Carros headquarters serves as the strategic and operational core of Virbac, housing corporate management, global R&D direction, central administrative functions, and key manufacturing facilities.
The site features advanced research laboratories, modern production units compliant with international quality standards, and administrative buildings. It's a significant campus that has grown with the company since its inception.
The work culture at Virbac's headquarters is driven by innovation, scientific excellence, and a strong commitment to animal welfare. It fosters collaboration among diverse teams in R&D, manufacturing, and corporate functions.
As the birthplace of Virbac, the Carros headquarters is historically and strategically crucial. It symbolizes the company's origins and continues to drive its global innovation and expansion in animal health.
Virbac supports animal health globally through commercial subsidiaries in over 35 countries and product distribution in more than 100 countries. Its global footprint includes R&D centers, 10 major production sites, and sales networks across Europe, North & Latin America, Asia-Pacific, and Africa, enabling it to address diverse veterinary needs worldwide.
13ème rue L.I.D.
Carros
Alpes-Maritimes
France
Address: 3200 Meacham Blvd, Fort Worth, TX 76137
To serve the significant North American animal health market, managing product registrations, commercial strategies, and customer support tailored to regional needs for both companion animals and livestock.
Address: 12-14 Williamson Road, Ingleburn, NSW 2565 (Primary Manufacturing & Distribution Centre, previous main office often cited as Milperra)
To address the specific animal health challenges and market demands of Australia and New Zealand, including products for parasite control and production animal health.
Address: Rua Doutor Miguel Paulo Capalbo, 159, Vila Hamburguesa, São Paulo - SP, CEP 05305-020
To cater to the diverse and growing Latin American animal health sector, adapting global products to local conditions and developing solutions for regional diseases and farming practices.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Virbac' leadership includes:
Virbac has been backed by several prominent investors over the years, including:
Virbac's core executive leadership team has demonstrated stability over the last 12 months. Any changes are typically part of strategic succession planning or internal role evolutions, with no major disruptive C-suite hires or departures widely publicized externally.
Discover the tools Virbac uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Virbac commonly uses the email format firstname.lastname@virbac.com. Variations like [first_initial][lastname]@virbac.com might also be in use for some employees.
firstname.lastname@virbac.com
Format
jane.doe@virbac.com
Example
85%
Success rate
Virbac Corporate Website • March 14, 2024
Virbac reported its full-year 2023 financial results, highlighting a 4.9% organic revenue growth at constant exchange rates and scope, reaching €1,247.3 million. The current operating profit before depreciation of assets from acquisitions rose by 9.3% at constant rates....more
Virbac Corporate Website • February 8, 2024
Virbac announced its 2023 annual revenue of €1,247.3 million, marking a +2.7% total growth compared to 2022, and +4.9% at constant exchange rates and scope. Growth was driven by strong performance in Europe and Asia, particularly in the companion animal segment....more
GlobeNewswire • December 13, 2023
Virbac announced the acquisition of the remaining 90% stake in its Japanese distributor, Sasae Vet Products Co. Ltd., aiming to consolidate its presence and accelerate growth in Japan, the world's second-largest companion animal market....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Virbac, are just a search away.